IDO1 and neoplasm: IDO1 inhibitor 1-MT synergistically promoted the expression of IDO1 and antagonistically blocked the expression of TRAIL in IFN-primed AFMSCs, which resulted in the elimination of direct cytotoxicity of IFN-γ-primed AFMSCs to tumor cells.